Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.58 -0.02 (-3.33%)
As of 10:51 AM Eastern

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Key Stats

Today's Range
$0.58
$0.58
50-Day Range
$0.43
$0.60
52-Week Range
$0.31
$0.67
Volume
2,020 shs
Average Volume
9,266 shs
Market Capitalization
$13.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

PBSV Pharma-Bio Serv, Inc. - Seeking Alpha
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
PBSV Decisions Paying Off
PBSV Returns to Growth
PBSV Released Earnings and Declares Dividend
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $0.5499 at the beginning of the year. Since then, PBSV shares have increased by 5.5% and is now trading at $0.58.

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) issued its quarterly earnings results on Monday, March, 17th. The company reported $0.37 earnings per share for the quarter, beating analysts' consensus estimates of $0.02 by $0.35. The business had revenue of $2.47 million for the quarter, compared to the consensus estimate of $2.70 million. Pharma-Bio Serv had a negative net margin of 1.96% and a negative trailing twelve-month return on equity of 1.47%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

Last Earnings
3/17/2025
Today
7/10/2025
Next Earnings (Estimated)
9/15/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Consulting
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
CIK
1304161
Employees
185
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
5.27
P/E Growth
N/A
Net Income
-$780 thousand
Net Margins
-1.96%
Pretax Margin
-2.01%
Return on Equity
-1.47%
Return on Assets
-1.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.54
Quick Ratio
7.54

Sales & Book Value

Annual Sales
$9.51 million
Price / Sales
1.40
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
0.97

Miscellaneous

Outstanding Shares
22,932,000
Free Float
20,043,000
Market Cap
$13.30 million
Optionable
Not Optionable
Beta
0.68

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners